Coty Hit With Securities Fraud Lawsuit Over Allegedly Concealed Weakness

What happened

A securities class action has been filed against Coty, alleging the company concealed deteriorating trends between November 2025 and February 2026, before reporting a disastrous Q2 2026 earnings that sent shares plummeting and coincided with the CEO's abrupt departure. The lawsuit, announced by Hagens Berman, claims Coty misled investors about the health of its business during a period when internal metrics were worsening. This legal action compounds the operational challenges already evident in Coty's FY25 results: declining revenue, GAAP net losses, heavy leverage, and a struggling Consumer Beauty segment. While the suit is still in early stages, it raises the risk of costly settlements or judgments and further damages management's credibility during a fragile turnaround effort.

Implication

For long-term investors, the lawsuit is one more headwind in an already high-risk story. Coty's fragile balance sheet (net debt/EBITDA 4.2x, interest coverage ~1.1x) leaves little room for legal costs or settlements. The class period coincides with a time when the company was supposedly executing its transformation, suggesting either ineptitude or concealment—neither is confidence-inspiring. While the suit may ultimately be dismissed or settled for a manageable sum, it adds uncertainty to the already speculative turnaround thesis. The DCF-based intrinsic value of ~$4.35 offers a potential upside, but only if the company can stabilize revenues, reduce leverage, and avoid large cash outflows. Given the lawsuit, the probability of achieving that within a reasonable timeframe has diminished. Investors should monitor developments closely but consider reducing exposure if legal costs mount or further negative operational surprises emerge.

Thesis delta

The securities lawsuit shifts the risk profile from purely operational and financial to include material legal and reputational damage. Our prior WAIT stance already flagged high execution risk and balance sheet fragility; the lawsuit validates those concerns and adds a new vector for cash outflows and management distraction. This does not fundamentally change the long-term potential of Coty's prestige fragrance business, but it lowers the probability of a successful near-term turnaround and increases the likelihood of equity dilution or asset sales to cover liabilities. The thesis now leans more toward SELL unless the company can quickly resolve the suit and demonstrate clean operational momentum.